Toxicology studies in mice administered MTX-531 - final deliverables
Ended Awarded Last action
- Contract number
- 75N91026F00001
- Awardee
-
IIT Research Institute UEI DGBUFQYMKWB5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $68,323
Award facts
- Contract value 100% obligated
- $68,323.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- B599 Special Studies/Analysis- Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Chicago, IL 60616, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a $68,323 firm fixed-price delivery order to IIT Research Institute (IITRI) for toxicology studies in mice administered MTX-531, with a final completion date of May 9, 2026. This delivery order, which carries no set-aside designation, represents work performed under one of IITRI's larger Indefinite Delivery/Indefinite Quantity (IDIQ) vehicles—the $149.995 million PREVENT Cancer Preclinical Drug Development Program with the National Cancer Institute. The work will be conducted at IITRI's Chicago, Illinois location, where the organization leverages its expertise as a non-profit contract research organization subsidiary of the Illinois Institute of Technology.
IITRI specializes in preclinical drug development services, with particular strength in toxicology and safety assessments for investigational new drug applications across various therapeutic areas including oncology. This engagement falls within the organization's core competency of conducting GLP and non-GLP toxicology studies involving rodents and mice to support the drug development pipeline. The delivery order represents a discrete task order under the broader PREVENT Cancer program, enabling the National Cancer Institute to advance MTX-531 through critical preclinical safety evaluation phases required for progression toward clinical development.
Quick answers
Who was awarded contract 75N91026F00001?
75N91026F00001 was awarded to IIT Research Institute by National Cancer Institute (National Institutes of Health) on February 9, 2026.
How much is contract 75N91026F00001 worth?
The government has obligated $68,323 on 75N91026F00001.
Is contract 75N91026F00001 an order under another contract?
Yes. 75N91026F00001 is a delivery order under 75N91022D00016, an indefinite delivery contract.
Was contract 75N91026F00001 competed?
The extent of competition for 75N91026F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award